Cost Per Response/Remission Across Biologics for the Treatment of Biologic Naïve Patients with Moderate-To-Severe Ulcerative Colitis from the Italian Healthcare Provider Perspective

Full Text

Economic Effectiveness of Ceftaroline fosamil for The Treatment of Hospitalised Patients With Pneumococcal Community-Acquired Pneumonia from a Societal Perspective

Abstract

Authors

Y.A. Belkova S.A. Rachina R.S. Kozlov

Back to Volume 18, Issue 3

Economic Effectiveness of Ceftaroline fosamil for The Treatment of Hospitalised Patients With Pneumococcal Community-Acquired Pneumonia from a Societal Perspective

Abstract

Authors

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date